Cetuximab with chemotherapy (CT) as first-line treatment for metastatic colorectal cancer (mCRC): Analysis of the CRYSTAL and OPUS studies according to KRAS and BRAF mutation status. - Bokemeyer,C.; Kohne,C.; Rougier,P. (J Clin Oncol, 2010)